Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huyuan Yang

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Biology Reports|January 29, 2003
Future directions in protein function predictionIhsan A Shehadi, Huyuan Yang, Mary Jo Ondrechen
Biopolymers|January 22, 2011
High-performance prediction of functional residues in proteins with machine learning and computed input featuresSrinivas Somarowthu, Huyuan Yang, David G C Hildebrand, et al.
Journal of Molecular Evolution|September 3, 2010
Evolution of enzymatic activities of testis-specific short-chain dehydrogenase/reductase in DrosophilaJianming Zhang, Huyuan Yang, Manyuan Long, et al.
Proteins|March 2, 2005
Statistical criteria for the identification of protein active sites using Theoretical Microscopic Titration CurvesJaeju Ko, Leonel F Murga, Pierrette André, et al.
Targeted Oncology|August 14, 2017
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based AnalysesNeeraj Gupta, Huyuan Yang, Michael J Hanley, et al.
Cancer Research and Treatment|May 12, 2017
TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 StudyYung-Jue Bang, Toshimi Takano, Chia-Chi Lin, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studiesMaurizio Fava, Stephen R Wisniewski, Michael E Thase, et al.
British Journal of Clinical Pharmacology|April 29, 2016
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairmentNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
International Journal of Geriatric Psychiatry|September 10, 2010
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysisDavid C Steffens, J Craig Nelson, James M Eudicone, et al.
Clinical Pharmacology and Therapeutics|February 16, 2018
Model-Informed Drug Development for Ixazomib, an Oral Proteasome InhibitorNeeraj Gupta, Michael J Hanley, Paul M Diderichsen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Biology Reports|January 29, 2003
Future directions in protein function predictionIhsan A Shehadi, Huyuan Yang, Mary Jo Ondrechen
Biopolymers|January 22, 2011
High-performance prediction of functional residues in proteins with machine learning and computed input featuresSrinivas Somarowthu, Huyuan Yang, David G C Hildebrand, et al.
Journal of Molecular Evolution|September 3, 2010
Evolution of enzymatic activities of testis-specific short-chain dehydrogenase/reductase in DrosophilaJianming Zhang, Huyuan Yang, Manyuan Long, et al.
Proteins|March 2, 2005
Statistical criteria for the identification of protein active sites using Theoretical Microscopic Titration CurvesJaeju Ko, Leonel F Murga, Pierrette André, et al.
Targeted Oncology|August 14, 2017
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based AnalysesNeeraj Gupta, Huyuan Yang, Michael J Hanley, et al.
Cancer Research and Treatment|May 12, 2017
TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 StudyYung-Jue Bang, Toshimi Takano, Chia-Chi Lin, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studiesMaurizio Fava, Stephen R Wisniewski, Michael E Thase, et al.
British Journal of Clinical Pharmacology|April 29, 2016
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairmentNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.
International Journal of Geriatric Psychiatry|September 10, 2010
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysisDavid C Steffens, J Craig Nelson, James M Eudicone, et al.
Clinical Pharmacology and Therapeutics|February 16, 2018
Model-Informed Drug Development for Ixazomib, an Oral Proteasome InhibitorNeeraj Gupta, Michael J Hanley, Paul M Diderichsen, et al.
Pageof 2